1. A1.04 Type II collagen immune complex induce granulocyte dependent augmentation of chemokines via TLR4; a possible therapeutic target in early ra. (24th February 2016) Authors: Manivel, VA; Sohrabian, A; Elshafie, A; Rönnelid, J Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 1 Page Start: A2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A7.1 A new technique for the follow-up of patients with immune complex-mediated diseases. (13th February 2015) Authors: Sohrabian, A; Persson, B; Manivel, V Anand; Elbagir, S; Fromell, K; Malmström, V; Gunnarsson, I; Rönnelid, J Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 1 Page Start: A74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A9.01 Characterisation of extracellular histidyl-trnasynthethase in myositis. (24th February 2016) Authors: Fernandes-Cerqueira, C; Sohrabian, A; Albrecht, I; Notarnicola, A; Ossipova, E; Lengqvist, J; Fathi, M; Pruijn, GJ; Grunewald, J; Rönnelid, J; Lundberg, IE; Jakobsson, PJ Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 1 Page Start: A70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0085 Number of peptide-specific anti-citrullinated peptide antibodies in synovial fluid and in synovial fluid immune complexes associate with degree of radiological destruction and response to triamcinolone hexacetonide for knee synovitis in rheumatoid arthritis. (15th June 2017) Authors: Sohrabian, A; Alm, L Mathsson; Hansson, M; Lysholm, J; Cornillet, M; Knight, A; Skriner, K; Serre, G; Larsson, A; Weitoft, T; Rönnelid, J Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 509 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SAT0233 High anti-dsdna content in sle immune complexes is associated with clinical remission following belimumab treatment. (15th June 2017) Authors: Sohrabian, A; Parodis, I; Carlströmer-Berthén, N; Sjöwall, C; Jönsen, A; Zickert, A; Frodlund, M; Bengtsson, A; Gunnarsson, I; Rönnelid, J Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 861 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗